The simple answer to your question is CBAI is working thru all this with Mr Long's help, and when ready we will hear something from CBAI. In order to obtain maximum benefit from these changes some things have to be clarified.
And when I say I'm Long, that also means I have patience. I expect to see 50% revenue growth in 2Q, 100% revenue growth in 3Q, and 200% revenue growth in 4Q assuming we close the Biocells deal. I consider that progress for sure. And next year the China deal starts paying off. Did you know we have minimum revenue payments guaranteed in the contract with AXMP? It's in the annual 10K that came out recently. You might want to read it.
Don't worry about the mule going blind just load the wagon.